Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy
Clinical trial NCT05167721 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05167721
- Sponsor
- Mayo Clinic
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-15
- Primary completion
- 2026-12-01
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.